Extracellular Matrix in Heart Disease: Focus on Circulating Collagen Type I and III Derived Peptides as Biomarkers of Myocardial Fibrosis and Their Potential in the Prognosis of Heart Failure: A Concise Review
Top Cited Papers
Open Access
- 28 March 2022
- journal article
- review article
- Published by MDPI AG in Metabolites
- Vol. 12 (4) , 297
Abstract
Accumulating evidence indicates that two major proteins are responsible for the structural coherence of bounding cardiomyocytes. These biomolecules are known as myocardial fibrillar collagen type I (COL1) and type III (COL3). In addition, fibronectin, laminin, fibrillin, elastin, glycoproteins, and proteoglycans take part in the formation of cardiac extracellular matrix (ECM). In physiological conditions, collagen synthesis and degradation in human cardiac ECM are well-regulated processes, but they can be impaired in certain cardiovascular diseases, such as heart failure (HF). Myocardial remodeling is part of the central mechanism of HF and involves cardiomyocyte injury and cardiac fibrosis due to increased fibrillar collagen accumulation. COL1 and COL3 are predominantly involved in this process. Specific products identified as collagen-derived peptides are released in the circulation as a result of abnormal COL1 and COL3 turnover and myocardial remodeling in HF and can be detected in patients’ sera. The role of these products in the pathogenesis of cardiac fibrosis and the possible clinical implications are the focus of numerous investigations. This paper reviews recent studies on COL1- and COL3-derived peptides in patients with HF. Their potential application as indicators of myocardial fibrosis and prognostic markers of HF is also highlighted.Keywords
This publication has 92 references indexed in Scilit:
- Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart diseaseFibrogenesis & Tissue Repair, 2012
- Loss of PPARγ expression by fibroblasts enhances dermal wound closureFibrogenesis & Tissue Repair, 2012
- The extracellular matrix at a glanceJournal of Cell Science, 2010
- Myocardial Fibrosis as an Early Manifestation of Hypertrophic CardiomyopathyNew England Journal of Medicine, 2010
- Molecular Mechanism of Type I Collagen Homotrimer Resistance to Mammalian CollagenasesJournal of Biological Chemistry, 2010
- The extracellular matrix in development and morphogenesis: A dynamic viewDevelopmental Biology, 2010
- Association Between Elevated Fibrosis Markers and Heart Failure in the ElderlyCirculation: Heart Failure, 2009
- Extracellular Matrix Molecules: Potential Targets in PharmacotherapyPharmacological Reviews, 2009
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)European Heart Journal, 2008
- Expansion of acute myocardial infarction: an experimental study.Circulation, 1982